BAYER 25 mg Pill: white, capsule/oblong, 18mm
Generic Name: larotrectinib
The pill with imprint BAYER 25 mg (White, Capsule/Oblong, 18mm) has been identified as Vitrakvi 25 mg and is used for Solid Tumors. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for BAYER 25 mg
Vitrakvi
- Generic Name
- larotrectinib
- Imprint
- BAYER 25 mg
- Strength
- 25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayer HealthCare Pharmaceuticals Inc.
- National Drug Code (NDC)
- 50419-0390
See also:
More about Vitrakvi (larotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.